1st Apr 2015 06:45
LONDON (Alliance News) - Healthcare company BTG PLC Wednesday said it has started selling its DC Bead and Bead Block drug-diluting bead and embolisation products directly to physicians in 11 countries in Europe.
FTSE 250-listed BTG said it has recently expanded its European sales team in order to back the expansion of its product sales.
"We're pleased to be supplying our beads and Therasphere products directly to healthcare professionals in Europe," said John Sylvester, chief commercial officer for interventional medicine at BTG.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
BTG